Using drug-designing software, Stanford researchers found a new anesthetic that appears to work while maintaining blood pressure.
Researchers find that neural sleep patterns in fish are analogous to those in mammals, paving ways to develop sleep medication.
Stanford researchers regenerate ear hair cells in mice -- the first time it's been achieved in mature mammals -- with implications for treating vertigo.
A thyroid cancer patient has neck surgery that leaves no scar, in a new procedure and a first for Stanford surgeons.
Stanford researchers disprove the idea that legalizing medical marijuana will lead to fewer deaths from opioid overdoses.
Physician burnout costs health care organizations about $7,600 annually for each physician they employ, Stanford researchers have found.
A third of young athletes register high blood pressure, raising questions about their health — or about the new U.S. hypertension guidelines.
A Stanford psychiatrist argues that internet privacy is a mental health issue and an online bill of rights is needed in the U.S.
In a recent commentary, Alan Schatzberg speaks out about the potential harms, and many questions, that surround ketamine's use to treat depression.
Stanford researchers find that colorectal cancer is being diagnosed at later stages in younger patients, suggesting risk of the disease is growing.
Stanford researchers, seeking ways to regenerate muscle after injury, find a promising method using collagen and vascular cells.
If physicians follow the guidelines for patients with leg and lower back pain and wait before getting MRIs, it could save half a billion dollars a year.
Firefighters, lawyers, teachers and other professionals have plenty to teach physicians about avoiding burnout and finding meaning in their work.
In response to views that cigarettes were unhealthful, tobacco companies used images of medical professionals to sell their products.
In a southern African nation, a clinic is helping children who suffer from debilitating ear, nose and throat conditions that are rare in the U.S.
A push to personalize medicine can backfire when it comes to screening for colorectal cancer, says a Stanford gastroenterologist.